• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.医院药品不良反应自发报告的障碍与解决办法
Br J Clin Pharmacol. 2005 Dec;60(6):653-8. doi: 10.1111/j.1365-2125.2005.02504.x.
2
Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria.尼日利亚拉各斯一家教学医院的医生对药品不良反应报告的认知
BMC Clin Pharmacol. 2009 Aug 11;9:14. doi: 10.1186/1472-6904-9-14.
3
Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.药品不良反应报告不足:印度药物警戒面临的一项挑战。
Indian J Pharmacol. 2015 Jan-Feb;47(1):65-71. doi: 10.4103/0253-7613.150344.
4
Perception of pharmacovigilance among doctors in a tertiary care hospital: influence of an interventional lecture.三级护理医院医生对药物警戒的认知:一场干预性讲座的影响
Int J Risk Saf Med. 2013;25(4):197-204. doi: 10.3233/JRS-130598.
5
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
6
Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions.印度药品不良反应报告:当前情况、障碍及可能的解决办法综述
Int J Risk Saf Med. 2019;30(1):33-44. doi: 10.3233/JRS-180025.
7
Founding an adverse drug reaction (ADR) network: a method for improving doctors spontaneous ADR reporting in a general hospital.建立药物不良反应(ADR)网络:提高综合医院医生自发报告 ADR 的一种方法。
J Clin Pharmacol. 2013 Nov;53(11):1220-5. doi: 10.1002/jcph.149. Epub 2013 Aug 19.
8
A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.葡萄牙一个药物警戒中心10年活动期间药品不良反应自发报告情况调查。
Int J Pharm Pract. 2014 Aug;22(4):275-82. doi: 10.1111/ijpp.12078. Epub 2013 Nov 5.
9
Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital.教学医院医生中与药品不良反应报告相关的知识、态度和行为
Int J Risk Saf Med. 2011;23(4):227-32. doi: 10.3233/JRS-2011-0543.
10
Developing an adverse drug reaction reporting system at a teaching hospital.在一家教学医院建立药物不良反应报告系统。
Basic Clin Pharmacol Toxicol. 2008 Apr;102(4):408-11. doi: 10.1111/j.1742-7843.2008.00217.x. Epub 2008 Feb 29.

引用本文的文献

1
A qualitative study to investigate pharmacovigilance systems in Dubai hospitals.一项旨在调查迪拜医院药物警戒系统的定性研究。
PLoS One. 2025 Sep 10;20(9):e0331929. doi: 10.1371/journal.pone.0331929. eCollection 2025.
2
Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab.偏头痛预防性单克隆抗体的上市后安全性:基于EudraVigilance数据库对eptinezumab、fremanezumab、galcanezumab和erenumab的分析。
Headache. 2025 Jul-Aug;65(7):1080-1094. doi: 10.1111/head.14962. Epub 2025 May 29.
3
Pharmacovigilance for Vaccines Used in Pregnancy: A Gap Analysis From Uganda.孕期使用疫苗的药物警戒:来自乌干达的差距分析
Pediatr Infect Dis J. 2025 Feb 1;44(2S):S123-S129. doi: 10.1097/INF.0000000000004705. Epub 2025 Feb 14.
4
Machine learning to predict adverse drug events based on electronic health records: a systematic review and meta-analysis.基于电子健康记录的机器学习预测药物不良事件:系统评价与荟萃分析
J Int Med Res. 2024 Dec;52(12):3000605241302304. doi: 10.1177/03000605241302304.
5
Barriers in reporting adverse effects of medical devices: a literature review.医疗器械不良反应报告中的障碍:一项文献综述。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1145-1153. doi: 10.1007/s00210-024-03431-x. Epub 2024 Sep 11.
6
Identifying strategies to improve adverse drug reporting through key informant interviews among community pharmacists in a developing country.确定通过发展中国家社区药剂师的关键知情人访谈来改善不良药物报告的策略。
Sci Rep. 2024 Jul 22;14(1):16821. doi: 10.1038/s41598-024-67263-8.
7
An Awareness of Pharmacovigilance Among Healthcare Professionals Due to an Underreporting of Adverse Drug Reactions Issue: A Systematic Review of the Current State, Obstacles, and Strategy.由于不良反应报告不足问题,提高医疗保健专业人员对药物警戒的认识:当前状况、障碍和策略的系统评价。
Curr Drug Saf. 2024;19(3):317-331. doi: 10.2174/0115748863276456231016062628.
8
Exploration and Evaluation of Adverse Drug Reactions Documented in a Tertiary-Care Hospital in Chennai: An In-Depth Retrospective Observational Study.钦奈一家三级护理医院记录的药物不良反应的探索与评估:一项深入的回顾性观察研究。
Cureus. 2024 May 24;16(5):e60977. doi: 10.7759/cureus.60977. eCollection 2024 May.
9
Causality, Severity, Preventability and Predictability Assessments Scales for Adverse Drug Reactions: A Review.药物不良反应的因果关系、严重程度、可预防性和可预测性评估量表:综述
Cureus. 2024 May 9;16(5):e59975. doi: 10.7759/cureus.59975. eCollection 2024 May.
10
Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database.利用美国食品药品监督管理局不良事件报告系统(FAERS)数据库进行药物重新利用。
Curr Drug Targets. 2024;25(7):454-464. doi: 10.2174/0113894501290296240327081624.

本文引用的文献

1
Reasons for reporting adverse drug reactions--some thoughts based on an international review.报告药品不良反应的原因——基于一项国际综述的一些思考
Pharmacoepidemiol Drug Saf. 1997 Jan;6(1):21-6. doi: 10.1002/(SICI)1099-1557(199701)6:1<21::AID-PDS259>3.0.CO;2-I.
2
Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions.医生关于药品不良反应自发报告系统的知识与态度。
J Clin Epidemiol. 2002 Sep;55(9):945-50. doi: 10.1016/s0895-4356(02)00450-x.
3
Physicians' attitudes towards voluntary reporting of adverse drug events.医生对药品不良事件自愿报告的态度。
J Eval Clin Pract. 2001 Nov;7(4):347-54. doi: 10.1046/j.1365-2753.2001.00295.x.
4
Attitudes to reporting adverse drug reactions in northern Sweden.瑞典北部地区对药品不良反应报告的态度。
Eur J Clin Pharmacol. 2000 Dec;56(9-10):729-32. doi: 10.1007/s002280000202.
5
Attitudinal survey of voluntary reporting of adverse drug reactions.药品不良反应自愿报告态度调查
Br J Clin Pharmacol. 1999 Oct;48(4):623-7. doi: 10.1046/j.1365-2125.1999.00060.x.
6
150 years of pharmacovigilance.150年的药物警戒
Lancet. 1998 Apr 18;351(9110):1200-1. doi: 10.1016/S0140-6736(98)03148-1.
7
Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group.欧盟医疗保健专业人员药品不良反应报告态度调查。欧洲药物警戒研究小组。
Eur J Clin Pharmacol. 1997;52(6):423-7. doi: 10.1007/s002280050314.
8
Reporting of adverse drug reactions by hospital doctors and the response to intervention.医院医生对药品不良反应的报告及干预措施的应对情况
Br J Clin Pharmacol. 1997 Jul;44(1):98-100. doi: 10.1046/j.1365-2125.1997.00616.x.
9
Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.药物警戒:失而复得还是推迟到来?1994年威廉·威瑟林讲座
J R Coll Physicians Lond. 1995 Jan-Feb;29(1):41-9.
10
Qualitative research. Introducing focus groups.定性研究。引入焦点小组。
BMJ. 1995 Jul 29;311(7000):299-302. doi: 10.1136/bmj.311.7000.299.

医院药品不良反应自发报告的障碍与解决办法

Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.

作者信息

Vallano A, Cereza G, Pedròs C, Agustí A, Danés I, Aguilera C, Arnau J M

机构信息

Fundació Institut Català de Farmacologia, WHO Collaborating Centre for Research and Training in Pharmacoepidemiology, Barcelona, Spain.

出版信息

Br J Clin Pharmacol. 2005 Dec;60(6):653-8. doi: 10.1111/j.1365-2125.2005.02504.x.

DOI:10.1111/j.1365-2125.2005.02504.x
PMID:16305591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1884880/
Abstract

AIM

To describe the opinions of hospital physicians concerning problems regarding the spontaneous reporting of adverse drug reactions (ADRs) and ways to solve them.

METHODS

A qualitative study was carried out. Fifteen focus groups were conducted among physicians working in a tertiary teaching hospital. A total of 208 physicians from different medical specialities participated. The focus group discussions were recorded by three different observers and the transcripts of each session were analysed for issues and themes emerging from the text.

RESULTS

Four types of obstacles to spontaneous reporting were considered particularly important: (i) problems with the ADR(S) diagnosis; (ii) problems with the usual workload and lack of time; (iii) problems related to the organization and activities of the pharmacovigilance system; (iv) and problems related to potential conflicts. The potential solutions suggested for improving spontaneous reporting were to define the kind of ADR(S) which should be reported, to facilitate an easy contact and quick access to the hospital pharmacovigilance system, to facilitate information and support for reporting and feedback of pharmacovigilance activities.

CONCLUSIONS

The perception of the different obstacles by the hospital physicians is an important factor in determining the causes of the underreporting of ADRs and addressing these obstacles could lead to an improvement in spontaneous reporting. A closer relationship between the doctors and the pharmacovigilance centre is suggested as a means of solving these problems. More information is needed to improve the spontaneous reporting of ADR(S) in specialized healthcare.

摘要

目的

描述医院医生对药品不良反应(ADR)自发报告相关问题及解决方法的看法。

方法

开展一项定性研究。在一家三级教学医院工作的医生中进行了15次焦点小组讨论。共有来自不同医学专业的208名医生参与。焦点小组讨论由三名不同的观察者进行记录,并对每次会议的文字记录进行分析,以找出文本中出现的问题和主题。

结果

自发报告的四类障碍被认为尤为重要:(i)ADR诊断问题;(ii)日常工作量和时间不足问题;(iii)与药物警戒系统的组织和活动相关的问题;(iv)与潜在冲突相关的问题。为改善自发报告提出的潜在解决方案包括明确应报告的ADR类型,便利与医院药物警戒系统的轻松联系和快速访问,便利药物警戒活动报告和反馈的信息及支持。

结论

医院医生对不同障碍的认知是确定ADR报告不足原因的重要因素,解决这些障碍可能会改善自发报告情况。建议医生与药物警戒中心建立更紧密的关系作为解决这些问题的一种方式。需要更多信息来改善专科医疗中ADR的自发报告。